A randomised clinical trial (RCT) of the effect of Neuro-Emotional Technique (NET) on the clinical manifestations of primary overt hypothyroidism
Phase 3
Completed
- Conditions
- HypothyroidismMetabolic and Endocrine - Other metabolic and endocrine disorders
- Registration Number
- ACTRN12607000040460
- Lead Sponsor
- A/Prof Rod Bonello
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
Hypothyroid sufferers.
Exclusion Criteria
Iatrogenic hypothyroidism, < 18 years, significant co-morbidities, Deaf/mute, Non-English speaking, Serious illness/mental illness, Pregnant, Individuals recently diagnosed (within the last 6 months) with hypothyroidism, medications that are known to influence thyroid function other than standard meds for hypothyroidism.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the influence of Neuro-Emotional Technique (NET) on the clinical manifestations of individuals with primary overt hypothyroidism. Outcome measures include: Depression scores as measured by the Depression, Anxiety, Stress (DASS) questionnaire.[Administered at the beginning of the trial, and at 6 weeks and 6 months.]
- Secondary Outcome Measures
Name Time Method